| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 269 |
| 1 | TOCILIZUMAB | 269 |
| 2 | ABATACEPT | 268 |
| 3 | ETANERCEPT | 268 |
| 4 | INFLIXIMAB | 267 |
| 5 | SULFASALAZINE | 267 |
| 6 | ADALIMUMAB | 266 |
| 7 | ANAKINRA | 265 |
| 8 | METHOTREXATE | 253 |
| 9 | PREDNISONE | 253 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 114 | 0.6264 |
| 1 | VACCINIA IMMUNE GLOBULIN (HUMAN) | 1 | 0.1667 |
| 2 | ANAKINRA | 265 | 0.0270 |
| 3 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0270 |
| 4 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 103 | 0.0129 |
| 5 | TRIAMCINOLONE ACETONIDE | 103 | 0.0057 |
| 6 | SULFASALAZINE | 267 | 0.0052 |
| 7 | TOCILIZUMAB | 269 | 0.0041 |
| 8 | ABATACEPT | 268 | 0.0031 |
| 9 | HYDROXYCHLOROQUINE SULFATE | 146 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 282 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 269 |
| 2 | Aminosalicylate [EPC] | 268 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 268 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 265 |
| 5 | Corticosteroid [EPC] | 263 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 253 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 199 |
| 8 | Vitamin B12 [EPC] | 47 |
| 9 | Vitamin C [EPC] | 47 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 265 | 0.0270 |
| 1 | Human Immunoglobulin G [EPC] | 2 | 0.0046 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 269 | 0.0037 |
| 3 | Aminosalicylate [EPC] | 268 | 0.0033 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 268 | 0.0031 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 253 | 0.0008 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 282 | 0.0004 |
| 7 | Corticosteroid [EPC] | 263 | 0.0003 |
| 8 | Vitamin D [EPC] | 47 | 0.0003 |
| 9 | Vitamin B12 [EPC] | 47 | 0.0002 |